| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Fuller RW, Hines CW, Mill... |
Lowering of Brain Serotonin Levels by Chloramphetamines |
Biochem Pharmacol |
1965 |
| Fuller RW, Mills J, Marsh... |
Inhibition of phenethanolamine N-methyl transferase by ring-substitute... |
J Med Chem |
1971 |
| Fuller RW, Snoddy HD, Mol... |
Effect of β,β-difluoro substitution on the disposition and p... |
J Pharmacol Exp Ther |
1973 |
| Fuller RW, Snoddy HD |
Long-term effects of 4-chloroamphetamine on brain 5-hydroxyindole meta... |
Neuropharmacology |
1974 |
| Fuller RW, Perry KW, Wong... |
Effects of some homologues of 4-chloroamphetamine on brain serotonin m... |
Neuropharmacology |
1974 |
| Fuller RW, Perry KW |
Long-lasting depletion of brain serotonin by 4-chloroamphetamine in gu... |
Brain Res |
1974 |
| Bertilsson L, Koslow SH, ... |
5-Hydroxytryptamine depletion in mesencephalic nuclei of rat brain fol... |
Brain Res |
1975 |
| Herman ZS |
5-Hydroxytptamine Metabolism in the Brain Under the Influence of Psych... |
Pol.J.Pharmacol.Phar... |
1975 |
| Fuller RW, Perry KW, Moll... |
Reversible and irreversible phases of serotonin depletion by 4-chloroa... |
Eur J Pharmacol |
1975 |
| Maj J |
The influence of dopaminergic agents on the serotoninergic neurons |
Pol J Pharmacol Phar... |
1975 |
| Lopatka JE, Brewerton CN,... |
The protective effects of methysergide, 6-hydroxydopamine and other ag... |
Res Commun Chem Path... |
1976 |
| Fuller RW, Perry KW |
Inability of methadone to prevent the depletion of brain 5-hydroxyindo... |
Biochem Pharmacol |
1976 |
| Davis M, Sheard MH |
p-Chloroamphetamine PCA: acute and chronic effects on habituation and ... |
Eur J Pharmacol |
1976 |
| Appel JB |
Neurohumoral Determinants of Sensitivity to LSD |
Psychopharmacol. Bul... |
1976 |
| Maj J, Baran L, Rawlow A,... |
Central effects of miaserin and danitracen - New antidepressants of un... |
Pol.J.Pharmacol.Phar... |
1977 |
| Fuxe K, Ogren SO, Agnati ... |
5,7-Dihydroxytryptamine as a Tool to Study the Functional Role of Cent... |
Ann.N.Y.Acad.Sci. |
1978 |
| Rech RH |
Brain Lesions and Psychostimulant Drugs |
Psychopharmacol.Bull... |
1978 |
| Conde S, Madroņero R, Fer... |
Effects of thiophene analogues of chloroamphetamines on central seroto... |
J Med Chem |
1978 |
| Fuller RW, Meyers DB, Gib... |
Depletion of brain serotonin by chronic administration of p-chloramphe... |
Toxicol Appl Pharmac... |
1979 |
| Fuller RW, Kaiser C |
Effect of 2-(p-chlorophenyl)cyclopropylamine on 5-hydroxyindole concen... |
Biochem Pharmacol |
1980 |
| Maj J, Vetulani J, Michal... |
Central Action of Amitriptyline N-oxide |
Pharmacopsychiat. |
1982 |
| Stone DM, Stahl DC, Hanso... |
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... |
Eur J Pharmacol |
1986 |
| Steranka LR, Rhind AW |
Effect of cysteine on the persistent depletion of brain monoamines by ... |
Eur J Pharmacol |
1987 |
| Gibb JW, Stone DM, Stahl ... |
The effects of amphetamine-like designer drugs on monoaminergic system... |
NIDA Res Monogr |
1987 |
| Schmidt CJ |
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphet... |
J Pharmacol Exp Ther |
1987 |
| Mamounas LA, Molliver ME |
Evidence for dual serotonergic projections to neocortex: axons from th... |
Exp Neurol |
1988 |
| Gazzara RA, Takeda H, Cho... |
Inhibition of dopamine release by methylenedioxymethamphetamine is med... |
Eur J Pharmacol |
1989 |
| Hiramatsu M, Nabeshima T,... |
The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MD... |
Pharmacol Biochem Be... |
1989 |
| Johnson M, Stone DM, Bush... |
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... |
Eur J Pharmacol |
1989 |
| Lim HK, Foltz RL |
Identification of metabolites of 3,4-(methylenedioxy)methamphetamine i... |
Chem Res Toxicol |
1989 |
| Slikker W Jr, Holson RR, ... |
Behavioral and neurochemical effects of orally administered MDMA in th... |
Neurotoxicology |
1989 |
| Sprouse JS, Bradberry CW,... |
MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal... |
Eur J Pharmacol |
1989 |
| Stone DM, Hanson GR, Gibb... |
In vitro reactivation of rat cortical tryptophan hydroxylase following... |
J Neurochem |
1989 |
| Hiramatsu M, Cho AK |
Enantiomeric differences in the effects of 3,4-methylenedioxymethamphe... |
Neuropharmacology |
1990 |
| Johnson MP, Huang XM, Obe... |
Behavioral, biochemical and neurotoxicological actions of the alpha-et... |
Eur J Pharmacol |
1990 |
| Schmidt CJ, Kehne JH |
Neurotoxicity of MDMA: neurochemical effects |
Ann N Y Acad Sci |
1990 |
| Callaway CW, Johnson MP, ... |
Amphetamine derivatives induce locomotor hyperactivity by acting as in... |
Psychopharmacology (... |
1991 |
| Champney TH, Matthews RT |
Pineal serotonin is resistant to depletion by serotonergic neurotoxins... |
J Pineal Res |
1991 |
| Huang XM, Johnson MP, Nic... |
Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) |
Eur J Pharmacol |
1991 |
| Johnson MP, Conarty PF, N... |
[3H]monoamine releasing and uptake inhibition properties of 3,4-methyl... |
Eur J Pharmacol |
1991 |
| Nash JF, Nichols DE |
Microdialysis studies on 3,4-methylenedioxyamphetamine and structurall... |
Eur J Pharmacol |
1991 |
| Nichols DE, Johnson MP, O... |
5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine |
Pharmacol Biochem Be... |
1991 |
| Fuller RW |
Effects of p-chloroamphetamine on brain serotonin neurons |
Neurochem Res |
1992 |
| Berger UV, Gu XF, Azmitia... |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, metham... |
Eur J Pharmacol |
1992 |
| Farfel GM, Vosmer GL, Sei... |
The N-methyl-D-aspartate antagonist MK-801 protects against serotonin ... |
Brain Res |
1992 |
| Huang X, Marona-Lewicka D... |
p-Methylthioamphetamine is a Potent New Non-Neurotoxic Serotonin-Relea... |
Eur J Pharmacol |
1992 |
| Kehne JH, McCloskey TC, T... |
Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (... |
J Pharmacol Exp Ther |
1992 |
| Huang X, Marona-Lewicka D... |
p-methylthioamphetamine is a potent new non-neurotoxic serotonin-relea... |
Eur J Pharmacol |
1992 |
| Colado MI, Murray TK, Gre... |
5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MD... |
Br J Pharmacol |
1993 |
| Gu XF, Azmitia EC |
Integrative transporter-mediated release from cytoplasmic and vesicula... |
Eur J Pharmacol |
1993 |
| Schuldiner S, Steiner-Mor... |
Amphetamine Derivatives Interact with Both Plasma Membrane and Secreto... |
Mol Pharmacol |
1993 |
| Colado MI, Green AR |
A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of ... |
Br J Pharmacol |
1994 |
| Marona-Lewicka D, Nichols... |
Behavioral effects of the highly selective serotonin releasing agent 5... |
Eur J Pharmacol |
1994 |
| Series HG, Cowen PJ, Shar... |
p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) a... |
Psychopharmacology (... |
1994 |
| Kramer HK, Poblete JC, Az... |
3,4-Methylenedioxymethamphetamine ('Ecstasy') promotes the translocati... |
Brain Res |
1995 |
| Sabol KE, Richards JB, La... |
Amphetamine analogs have differential effects on DRL 36-s schedule per... |
Psychopharmacology (... |
1995 |
| Wall SC, Gu H, Rudnick G |
Biogenic amine flux mediated by cloned transporters stably expressed i... |
Mol Pharmacol |
1995 |
| Marona-Lewicka D, Rhee GS... |
Psychostimulant-like effects of p-fluoroamphetamine in the rat |
Eur J Pharmacol |
1995 |
| Sprague JE, Johnson MP, S... |
Studies on the mechanism of p-chloroamphetamine neurotoxicity |
Biochem Pharmacol |
1996 |
| Geyer MA |
Serotonergic functions in arousal and motor activity |
Behav Brain Res |
1996 |
| Murray TK, Williams JL, M... |
The spin trap reagent PBN attenuates degeneration of 5-HT neurones in ... |
Neuropharmacology |
1996 |
| Kehne JH, Padich RA, Kett... |
5-HT modulation of auditory and visual sensorimotor gating: I. Effects... |
Psychopharmacology (... |
1996 |
| Crespi D, Mennini T, Gobb... |
Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induc... |
Br J Pharmacol |
1997 |
| Colado MI, O'Shea E, Gran... |
In vivo evidence for free radical involvement in the degeneration of r... |
Br J Pharmacol |
1997 |
| Kramer HK, Poblete JC, Az... |
Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetam... |
Neuropsychopharmacol... |
1997 |
| Metzger RR, Hanson GR, Gi... |
3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine tr... |
Eur J Pharmacol |
1998 |
| Ana Garcia-Osta A, Frechi... |
Effect of p-Chloroamphetamine on 5-HT1A and 5-HT7 Serotonin Receptor E... |
J Neurochemistry |
2000 |
| Darvesh AS, Shankaran M, ... |
3,4-methylenedioxymethamphetamine produces glycogenolysis and increase... |
J Pharmacol Exp Ther |
2002 |
| Gobbi M, Moia M, Pirona L... |
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neur... |
J Neurochem |
2002 |
| Garcia-Osta A, Del Rio J,... |
Increased CRE-binding activity and tryptophan hydroxylase mRNA express... |
Brain Res Mol Brain ... |
2004 |
| Wang X, Baumann MH, Xu H,... |
3,4-methylenedioxymethamphetamine (MDMA) administration to rats decrea... |
Synapse |
2004 |
| Barnett RY, Baker DD, Kel... |
A fatal intoxication of 2,5-dimethoxy-4-chloroamphetamine: a case repo... |
J Anal Toxicol |
2014 |
